Pharmaceuticals,
Год журнала:
2021,
Номер
14(1), С. 42 - 42
Опубликована: Янв. 8, 2021
Metformin
(MF),
a
first-line
drug
to
treat
type
2
diabetes
mellitus
(T2DM),
alone
and
in
combination
with
other
drugs,
restores
the
ovarian
function
women
polycystic
ovary
syndrome
(PCOS)
improves
fetal
development,
pregnancy
outcomes
offspring
health
gestational
(GDM)
T2DM.
MF
treatment
is
demonstrated
improve
efficiency
of
vitro
fertilization
considered
supplementary
assisted
reproductive
technologies.
administration
shows
positive
effect
on
steroidogenesis
spermatogenesis
men
metabolic
disorders,
thus
indicates
prospective
use
for
improvement
male
functions
fertility.
lacks
teratogenic
effects
has
newborns.
The
review
focused
therapy
restoration
female
endocrine
disorders.
mechanisms
action
are
discussed,
including
normalization
hormonal
status
PCOS,
GDM,
T2DM
functional
activity
regulation
gonadal
axis.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Апрель 26, 2022
Alzheimer's
disease
(AD)
is
the
most
prevalent
neurodegenerative
worldwide,
characterized
by
progressive
neuron
degeneration
or
loss
due
to
excessive
accumulation
of
β-amyloid
(Aβ)
peptides,
formation
neurofibrillary
tangles
(NFTs),
and
hyperphosphorylated
tau.
The
treatment
AD
has
been
only
partially
successful
as
majority
pharmacotherapies
on
market
may
alleviate
some
symptoms.
In
occurrence
AD,
increasing
attention
paid
neurodegeneration,
while
resident
glial
cells,
like
microglia
are
also
observed.
Microglia,
a
kind
crucial
cells
associated
with
innate
immune
response,
functions
double-edge
sword
role
in
CNS.
They
exert
beneficial
detrimental
influence
adjacent
neurons
through
secretion
both
pro-inflammatory
cytokines
well
neurotrophic
factors.
addition,
their
endocytosis
debris
toxic
protein
Aβ
tau
ensures
homeostasis
neuronal
microenvironment.
this
review,
we
will
systematically
summarize
recent
research
regarding
roles
pathology
latest
microglia-associated
therapeutic
targets
mainly
including
genes,
anti-inflammatory
genes
phagocytosis
at
length,
which
contradictory
controversial
warrant
further
be
investigated.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(3), С. 1264 - 1264
Опубликована: Янв. 23, 2022
Metformin
is
the
most
commonly
used
treatment
to
increase
insulin
sensitivity
in
insulin-resistant
(IR)
conditions
such
as
diabetes,
prediabetes,
polycystic
ovary
syndrome,
and
obesity.
There
a
well-documented
correlation
between
glucose
transporter
4
(GLUT4)
expression
level
of
IR.
Therefore,
observed
peripheral
utilization
after
metformin
likely
comes
from
induction
GLUT4
its
increased
translocation
plasma
membrane.
However,
mechanisms
behind
this
effect
critical
targets
are
still
largely
undefined.
The
present
review
explores
evidence
for
crucial
role
changes
activation
signaling
pathway
mediators,
AMPK,
several
posttranscriptional
modifications
based
on
previously
published
preclinical
clinical
models
metformin's
mode
action
animal
human
studies.
Our
aim
provide
comprehensive
studies
field
order
shed
some
light
complex
interactions
action,
expression,
translocation,
sensitivity.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Апрель 18, 2024
Abstract
Cancer,
a
complex
and
multifactorial
disease,
presents
significant
challenge
to
global
health.
Despite
advances
in
surgical,
radiotherapeutic
immunological
approaches,
which
have
improved
cancer
treatment
outcomes,
drug
therapy
continues
serve
as
key
therapeutic
strategy.
However,
the
clinical
efficacy
of
is
often
constrained
by
resistance
severe
toxic
side
effects,
thus
there
remains
critical
need
develop
novel
therapeutics.
One
promising
strategy
that
has
received
widespread
attention
recent
years
repurposing:
identification
new
applications
for
existing,
clinically
approved
drugs.
Drug
repurposing
possesses
several
inherent
advantages
context
since
repurposed
drugs
are
typically
cost-effective,
proven
be
safe,
can
significantly
expedite
development
process
due
their
already
established
safety
profiles.
In
light
this,
present
review
offers
comprehensive
overview
various
methods
employed
repurposing,
specifically
focusing
on
treat
cancer.
We
describe
antitumor
properties
candidate
drugs,
discuss
detail
how
they
target
both
hallmarks
tumor
cells
surrounding
microenvironment.
addition,
we
examine
innovative
integrating
with
nanotechnology
enhance
topical
delivery.
also
emphasize
role
play
when
used
part
combination
regimen.
To
conclude,
outline
challenges
associated
consider
future
prospects
these
transitioning
into
application.
Drug Design Development and Therapy,
Год журнала:
2023,
Номер
Volume 17, С. 1907 - 1932
Опубликована: Июнь 1, 2023
Metformin
has
been
designated
as
one
of
the
most
crucial
first-line
therapeutic
agents
in
management
type
2
diabetes
mellitus.
Primarily
being
an
antihyperglycemic
agent,
metformin
also
a
plethora
pleiotropic
effects
on
various
systems
and
processes.
It
acts
majorly
by
activating
AMPK
(Adenosine
Monophosphate-Activated
Protein
Kinase)
cells
reducing
glucose
output
from
liver.
decreases
advanced
glycation
end
products
reactive
oxygen
species
production
endothelium
apart
regulating
lipid
metabolism
cardiomyocytes,
hence
minimizing
cardiovascular
risks.
Its
anticancer,
antiproliferative
apoptosis-inducing
malignant
might
prove
instrumental
malignancy
organs
like
breast,
kidney,
brain,
ovary,
lung,
endometrium.
Preclinical
studies
have
shown
some
evidence
metformin's
neuroprotective
role
Parkinson's
disease,
Alzheimer's
multiple
sclerosis
Huntington's
disease.
exerts
its
through
varied
pathways
intracellular
signalling
exact
mechanism
majority
them
remains
yet
to
be
clearly
defined.
This
article
extensively
reviewed
benefits
details
for
molecule
boon
conditions
diabetes,
prediabetes,
obesity,
polycystic
ovarian
metabolic
derangement
HIV,
cancers
aging.
It
has
long
been
established
that
stress
a
significant
impact
on
metabolic
function.
Type
2
diabetes
may
be
initiated
by
psychological
and
physical
stress.
The
central
peripheral
nervous
systems
are
both
involved
in
the
neuroendocrine
framework
underlies
underlying
processes.
release
of
catecholamines
rise
serum
glucocorticoid
concentrations
caused
enhance
requirement
for
insulin
resistance.
Experiencing
persistent
hyperglycemia
people
with
influenced
Blood
sugar
levels
due
to
hormones
being
released
response
Although
this
adaptive
significance
healthy
patient,
run,
it
can
cause
resistance
lead
diabetes.
Additionally,
abnormalities
regulation
these
hormones.
World Journal of Diabetes,
Год журнала:
2023,
Номер
14(4), С. 396 - 411
Опубликована: Апрель 11, 2023
The
global
prevalence
of
obesity
is
increasing
rapidly
with
an
exponential
rise
in
incidence
type
2
diabetes
mellitus
recent
years.
'Diabesity',
the
term
coined
to
show
strong
interlink
between
and
diabetes,
direct
cons-equence
pandemic,
poses
significant
challenges
management
disease.
Without
addressing
clinical
mechanistic
complications
such
as
metabolic-associated
fatty
liver
disease
obstructive
sleep
apnoea,
a
rational
algorithm
for
diabesity
cannot
be
developed.
Several
classes
anti-diabetic
medications
including
insulins,
sulphonylureas,
thiazolidinediones
meglitinides
are
associated
risk
weight
gain
may
potentially
worsen
diabesity.
Therefore,
appropriate
selection
antidiabetic
drug
regimen
crucial
medical
role
non-pharmacological
measures
dietary
adjustments,
exercise
interventions
bariatric
procedures
should
also
emphasised.
Unfortunately,
importance
optimal
often
overlooked
by
professionals
when
achieving
adequate
glycemic
control
which
results
inappropriate
its
complications.
This
review
provides
narrative
update
on
evidence
behind
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Фев. 2, 2024
Abstract
Neuroinflammation
is
a
pathological
hallmark
of
Alzheimer’s
disease
(AD),
characterized
by
the
stimulation
resident
immune
cells
brain
and
penetration
peripheral
cells.
These
inflammatory
processes
facilitate
deposition
amyloid-beta
(Aβ)
plaques
abnormal
hyperphosphorylation
tau
protein.
Managing
neuroinflammation
to
restore
homeostasis
decrease
neuronal
damage
therapeutic
approach
for
AD.
One
way
achieve
this
through
exercise,
which
can
improve
function
protect
against
neuroinflammation,
oxidative
stress,
synaptic
dysfunction
in
AD
models.
The
neuroprotective
impact
exercise
regulated
various
molecular
factors
that
be
activated
same
as
administration
their
mimetics.
Recent
evidence
has
proven
some
mimetics
effective
alleviating
AD,
and,
additionally,
they
are
helpful
alternative
option
patients
who
unable
perform
regular
physical
manage
neurodegenerative
disorders.
This
review
focuses
on
current
state
knowledge
mimetics,
including
efficacy,
regulatory
mechanisms,
progress,
challenges,
limitations,
future
guidance
application
therapy.
Translational Oncology,
Год журнала:
2024,
Номер
44, С. 101945 - 101945
Опубликована: Март 30, 2024
Metformin,
as
the
preferred
antihyperglycemic
drug
for
type
2
diabetes,
has
been
found
to
have
a
significant
effect
in
inhibiting
tumor
growth
recent
years.
However,
metformin
alone
cancer
treatment
disadvantages
of
high
dose
concentrations
and
few
targeted
types.
Increasing
studies
confirmed
that
can
be
used
combination
with
conventional
anticancer
therapy
obtain
more
promising
clinical
benefits,
which
is
expected
rapidly
transformed
applied
clinic.
Some
strategies
including
combined
chemotherapy,
radiotherapy,
immunotherapy
proven
antitumor
effects
longer
survival
time
than
monotherapy.
In
this
review,
we
summarize
synergistic
mechanisms
other
current
therapies.
addition,
update
research
progress
latest
prospect
metformin-combined
application
treatment.
This
work
could
provide
evidence
future
direction
antitumor.